Potential of plant oils as inhibitors of Candida albicans growth

被引:61
作者
Devkatte, AN [1 ]
Zore, GB [1 ]
Karuppayil, SM [1 ]
机构
[1] SRTM Univ, Sch Life Sci, Nanded 431606, MS, India
关键词
antifungal; Candida albicans; plant oils; fluconazole; amphotericin B;
D O I
10.1016/j.femsyr.2005.02.003
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Minimum inhibitory concentrations (MICs) and minimum fungicidal concentrations (MFCs) were determined for 38 oils of plant origin against Candida albicans. Four strains including one standard strain were used in this study. The antifungal agents, Fluconazole and Amphotericin B. were used as positive controls. The standard strain (ATCC10231) used in this study was found to be highly resistant to Fluconazole: 3000 mu g ml(-1) of Fluconazole was required to inhibit the growth of this strain partially, and complete inhibition could not be achieved. Other Candida strains were sensitive to 5 mu g ml(-1) of Fluconazole. All the strains used were sensitive to Amphotericin B. Of the 38 oils tested, 23 were found effective and fifteen were ineffective. Based on their MFCs, effective oils were categorized into three categories. Seven oils, which exerted fungicidal effect at less than 0.15% concentration of oils, were grouped into the most effective class. The oils exhibiting MFCs in the range of 0.16-1.5% concentration were considered moderately effective. Nine oils, which required more than 1.5% concentration, were regarded as less effective. The Fluconazole-resistant strain (MTCC 227) was sensitive to at least 23 of the plant oils. Results of this study indicate that oils of plant origin may find use as potential anti-Candida agents. (c) 2005 Federation of European Microbiological Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:867 / 873
页数:7
相关论文
共 31 条
  • [1] Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance
    Albertson, GD
    Niimi, M
    Cannon, RD
    Jenkinson, HF
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (12) : 2835 - 2841
  • [2] Altman P, 1988, AUST J PHARM, V69, P276
  • [3] BAUER K, 1997, COMMON FRAGRANCES FL, P167
  • [4] BODLEY GP, 1992, CLIN INFECT DIS, V14, pS161
  • [5] A novel multidrug efflux transporter gene of the major facilitator superfamily from Candida albicans (FLU1) conferring resistance to fluconazole
    Calabrese, D
    Bille, J
    Sanglard, D
    [J]. MICROBIOLOGY-UK, 2000, 146 : 2743 - 2754
  • [6] Comparative in vitro antifungal activity of amphotericin B lipid complex, amphotericin B and fluconazole
    Carrillo-Muñoz, AJ
    Quindós, G
    Tur, C
    Ruesga, M
    Alonso, R
    del Valle, O
    Rodriguez, V
    Arévalo, MP
    Salgado, J
    Martin-Mazuelos, E
    Bornay-Llinares, FJ
    del Palacio, A
    Cuétara, M
    Gasser, I
    Hernández-Molina, JM
    Pemán, J
    [J]. CHEMOTHERAPY, 2000, 46 (04) : 235 - 244
  • [7] ANTIMICROBIAL ACTIVITY OF THE MAJOR COMPONENTS OF THE ESSENTIAL OIL OF MELALEUCA-ALTERNIFOLIA
    CARSON, CF
    RILEY, TV
    [J]. JOURNAL OF APPLIED BACTERIOLOGY, 1995, 78 (03): : 264 - 269
  • [8] SUSCEPTIBILITY OF PROPIONIBACTERIUM-ACNES TO THE ESSENTIAL OIL OF MELALEUCA-ALTERNIFOLIA
    CARSON, CF
    RILEY, TV
    [J]. LETTERS IN APPLIED MICROBIOLOGY, 1994, 19 (01) : 24 - 25
  • [9] CHOWDHARY AR, 2002, J AROM MED PL SCI S1, V22
  • [10] DEANS SG, 1991, MOD METHOD PLANT, V12, P309